Bayer AG said Thursday that it has signed an agreement to sell further Crop Science businesses to BASF SE for up to 1.7 billion euros ($2.07 billion) as part of its planned acquisition of Monsanto Co.
These businesses generated sales of EUR745 million euros in 2017, Bayer said, and about 2,500 employees will transfer to chemicals company BASF as part of the deal. Bayer will use the proceeds–after taxes and adjustments–to help finance its proposed acquisition of Monsanto.
The businesses to be divested include the global vegetable-seeds business, certain seed-treatment products, the research platform for wheat hybrids and certain glyphosate-based herbicides in Europe that are predominantly used in industrial applications, Bayer said.
In addition, three research projects in the area of herbicides and Bayer’s digital-farming business will be transferred to BASF. Bayer will receive a back license for certain digital-farming applications in return, it said.
Last year, Bayer and BASF had already reached an agreement for the sale of certain Crop Science businesses for EUR5.9 billion. The businesses in that package–including Bayer’s glufosinate-ammonium business and related LibertyLink technology for herbicide tolerance, along with essentially all the company’s field-crop seeds businesses–generated 2017 sales of EUR1.5 billion.
The deal is subject to regulatory approval and the successful closing of Bayer’s acquisition of Monsanto.
By Sarah Sloat
Source: MarketWatch
Neste Corporation’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard) as the President and CEO of Neste as of 2 November 2024, at the latest. Malinen joins Neste from Outokumpu Corporation where he has held the position of President and CEO since 2020.
Petrochemicals company Sasol has announced that CFO and executive director Hanré Rossouw will step down from his position, effective October 31. Sasol has started the process to appoint a successor. Rossouw will still oversee the publication of Sasol’s reports for the financial year ending June 30, to allow for a structured handover period.
Chemours announced its CFO Jonathan Lock has resigned from all positions within the company, according to an SEC 8-K filing on April 23. The resignation comes in the aftermath of the company announcing that Lock, former CEO Mark Newman, and principal accounting officer Camela Wisel, had been placed on administrative leave.
